Literature DB >> 15927671

Induction of CXC and CC chemokines by all-trans retinoic acid in acute promyelocytic leukemia cells.

Misako Shibakura1, Kenji Niiya, Masami Niiya, Noboru Asaumi, Chikamasa Yoshida, Yasunari Nakata, Mitsune Tanimoto.   

Abstract

We previously reported the induction of interleukin-8 (IL-8), one of the CXC chemokines, by all-trans retinoic acid (ATRA) in PL-21 and NB4 human myeloid leukemia cells, which may be implicated in APL differentiation syndrome that is a relatively frequent complication in patients with acute promyelocytic leukemia (APL) during treatment with ATRA. We, therefore, further investigated the effects of ATRA on the expression of chemokine family in NB4 cells and APL cells prepared from two APL patients. The RNase protection assay using a multi-probe template set for human chemokines revealed that ATRA induced gene expressions of a number of CC chemokines, such as monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in NB4 cells. Their antigen levels were also increased in the cultured media. APL cells prepared from two APL patients showed gene expression of chemokines, such as IL-8, MCP-1, MIP-1alpha, and MIP-1beta when stimulated with ATRA in vitro. Furthermore, serum levels of IL-8, MIP-1beta and RANTES were increased during the course of ATRA treatment in both APL patients who developed APL differentiation syndrome. These chemokines are all chemoattractants of particular inflammatory cell types, including neutrophils, monocytes and lymphocytes; therefore, the simultaneous induction of these chemokines after stimulation with ATRA may exacerbate the hyper-inflammation observed in ATRA-induced APL differentiation syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15927671     DOI: 10.1016/j.leukres.2005.01.005

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  7 in total

1.  Late-onset differentiation syndrome in a child with acute promyelocytic leukemia.

Authors:  Hisao Yoshida; Risa Matsumura; Emiko Sato; Yoshiko Hashii; Hideaki Ohta; Keiichi Ozono
Journal:  Int J Hematol       Date:  2010-08-04       Impact factor: 2.490

2.  Differentiation syndrome in promyelocytic leukemia: clinical presentation, pathogenesis and treatment.

Authors:  E M Rego; G C De Santis
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-10-24       Impact factor: 2.576

3.  Integrating microRNA and mRNA expression profiles of acute promyelocytic leukemia cells to explore the occurrence mechanisms of differentiation syndrome.

Authors:  Yingmei Zhang; Jinxiao Hou; Fei Ge; Fenglin Cao; Haitao Li; Ping Wang; Mengyuan Xu; Peng Song; Xiaoxia Li; Shuye Wang; Jinmei Li; Xueying Han; Yanhong Zhao; Yanhua Su; Yinghua Li; Shengjin Fan; Limin Li; Jin Zhou
Journal:  Oncotarget       Date:  2016-11-08

4.  Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-κB activation.

Authors:  Károly Jambrovics; Iván P Uray; Zsolt Keresztessy; Jeffrey W Keillor; László Fésüs; Zoltán Balajthy
Journal:  Haematologica       Date:  2018-09-20       Impact factor: 9.941

Review 5.  Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity.

Authors:  Alejandro Carazo; Kateřina Macáková; Kateřina Matoušová; Lenka Kujovská Krčmová; Michele Protti; Přemysl Mladěnka
Journal:  Nutrients       Date:  2021-05-18       Impact factor: 5.717

6.  Genomics and proteomics of immune modulatory effects of a butanol fraction of echinacea purpurea in human dendritic cells.

Authors:  Chien-Yu Wang; Vanisree Staniforth; Ming-Tsang Chiao; Chia-Chung Hou; Han-Ming Wu; Kuo-Chen Yeh; Chun-Houh Chen; Pei-Ing Hwang; Tuan-Nan Wen; Lie-Fen Shyur; Ning-Sun Yang
Journal:  BMC Genomics       Date:  2008-10-13       Impact factor: 3.969

7.  Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome.

Authors:  Luciana Yamamoto de Almeida; Diego Antonio Pereira-Martins; Ana Sílvia Gouvêa Lima; Márcia Sueli Baggio; Luisa Corrêa de Araujo Koury; Ana Paula Lange; Sarah Cristina Bassi; Priscila Santos Scheucher; Eduardo Magalhães Rego
Journal:  BMC Cancer       Date:  2020-08-28       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.